Saltar al contenido

Quest Diagnostics Inc (DGX) stock: revenue, earnings & dividend

Quest Diagnostics Inc (DGX, NYSE): revenue, earnings, dividend and balance sheet from official SEC filings.

Stock screener DGX · NYSE Gesundheitswesen US-NJ

Key figures

Fiscal year
2025
Revenue
11 bn $
Revenue growth
11.8 %
Revenue growth 5y (p.a.)
3.2 %
Net income
992 m $
Net margin
9 %
Operating margin
14.1 %
Earnings per share (diluted)
8.75 $
Dividend per share
–
Payout ratio
–
Consecutive dividend years
–
Consecutive dividend raises
–
Dividend growth 5y (p.a.)
–
Total assets
16.2 bn $
Equity
7.17 bn $
Equity ratio
44.2 %
Return on equity
13.8 %
Cash
420 m $
Operating cash flow
1.89 bn $
Free cash flow
1.36 bn $
Shares outstanding
110,019,073

History

Revenue by fiscal year

2016 7.21 bn $
2017 7.4 bn $
2018 7.53 bn $
2019 7.73 bn $
2020 9.44 bn $
2021 10.8 bn $
2022 9.88 bn $
2023 9.25 bn $
2024 9.87 bn $
2025 11 bn $

Net income by fiscal year

2016 645 m $
2017 772 m $
2018 736 m $
2019 858 m $
2020 1.43 bn $
2021 2 bn $
2022 946 m $
2023 854 m $
2024 871 m $
2025 992 m $

Dividend per share

2016 1.65 $
2017 1.80 $
YearRevenueNet incomeEPSDividend per shareOperating cash flow
202511 bn $992 m $8.75 $–1.89 bn $
20249.87 bn $871 m $7.69 $–1.33 bn $
20239.25 bn $854 m $7.49 $–1.27 bn $
20229.88 bn $946 m $7.97 $–1.72 bn $
202110.8 bn $2 bn $15.55 $–2.23 bn $
20209.44 bn $1.43 bn $10.47 $–2.01 bn $
20197.73 bn $858 m $6.28 $–1.24 bn $
20187.53 bn $736 m $5.29 $–1.2 bn $
20177.4 bn $772 m $5.50 $1.80 $1.18 bn $
20167.21 bn $645 m $4.51 $1.65 $1.12 bn $

Data from XBRL filings at the SEC, processed automatically, no guarantee. Not investment advice. All filings at the SEC (EDGAR)